Abbott Labs (ABT) PT Raised to $146 at Morgan Stanley
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Abbott Labs (ABT) PT Raised to $145 at Jefferies
October 21, 2021 7:56 AM EDTJefferies analyst Raj Denhoy raised the price target on Abbott Labs (NYSE: ABT) to $145.00 (from $135.00) while maintaining a Buy rating following earnings.
The analyst commented, "Key post call datapoints: 1) COVID testing still elevated with $1-$1.4bn baked into 4Q guide, 2) screening versus symptomatic testing... More



